Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Ireland’s Horizon Pharma to buy Hyperion for $1.1bn

      Europe
      Irish biopharmaceutical firm Horizon Pharma has signed an agreement to acquire US-based Hyperion Therapeutics for around $1.1bn.   As part of the deal, Horizon...

      CHMP recommends new single-pill combination therapy to treat type 2 diabetes

      Europe
         30 March 2015 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Boehringer Ingelheim (BI) and Eli...

      GSK to provide meningitis B vaccine in UK

      Europe
      GlaxoSmithKline (GSK) has entered an agreement with the UK's Department of Health to provide meningitis B vaccine for babies in the country.   Meningitis...

      GSK obtains Japanese approval for Encruse Ellipta to treat COPD

      Asia
      GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium).   The Japanese Ministry of Health, Labour and Welfare (MHLW) granted approval for...

      Multisorb to Attend Interphex 2015

      News
      Multisorb Technologies has announced it will be exhibiting at Interphex in New York. The event will take place from 20-22 April 2015 at the Javits...

      Signum out-licenses SIG990 to Dermata to develop new topical treatment for rosacea

      Americas
      US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a topical product to treat...

      Cipher Pharma buys Canadian rights to novel treatment for psoriasis and RA from Can-Fite Biopharma

      Americas
      Cipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.